United States · Series D startup
9 rounds we have observed, with the 14 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$112Mraised across 9 rounds since 2010, from 10 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Alexandria Real Estate Equities
Ysios Capital
Chiesi Ventures
Lundbeckfonden Ventures
Columbus
LI-CORReported by 4-traders and 1 otherSEC filing: $32M sold, first sale Dec 2017
Reported by FinSMEsSEC filing: $1.8M sold, first sale Sept 2016
From a historical funding recordSEC filing: $21M sold, first sale Feb 2015
No investor was named in the report.
From a historical funding recordSEC filing: $4.0M sold, first sale Apr 2014
No investor was named in the report.
From a historical funding recordSEC filing: $1.3M sold, first sale Aug 2013
No investor was named in the report.
Reported by sec.govSEC filing: $3.2M sold, first sale Aug 2012
No investor was named in the report.
Reported by masshightech.comSEC filing: $2.9M sold, first sale May 2011
No investor was named in the report.
Reported by masshightech.comSEC filing: $1.4M sold, first sale Sept 2010
From the SEC filings it signed: 2 on the team.
On the board, as filediDavid JohnsonGiovanni MariggiKaran TakharRaj Parekh
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Ysios CapitalChiesi VenturesAlexandria Real Estate Equities
Advent Life Sciences Llp
MedicxiLundbeckfonden VenturesHenri Termeer
Advent PartnersArix Bioscience/ Advent Life SciencesColumbusMissing a round, or an investor who was in one? Tell us.
These 4 firms list Aura Biosciences as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Aura Biosciences's investors include Ysios Capital, Chiesi Ventures, Alexandria Real Estate Equities, Advent Life Sciences Llp and Medicxi, and 9 more on record.
Aura Biosciences has raised $112M across 9 rounds since 2010.
Aura Biosciences's most recent round was a Series D of $40M in Apr 2019.
Its most recent round, $40M in Apr 2019, is also its largest on record.
Aura Biosciences's first round on record, in Mar 2015, was backed by Alexandria Real Estate Equities, Ysios Capital and Advent Life Sciences Llp and 2 others.
Aura Biosciences's latest named round is a Series D, in Apr 2019.
Aura Biosciences is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
